PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Nano-measurement of troponin levels proves an accurate predictor of deterioration in heart failure

Simple blood tests with new high sensitive assay show that even small changes accurately forecast 90-day prognosis

2010-12-14
(Press-News.org) Sophia Antipolis, 14 December 2010: Today, heart failure is by far the single biggest reason for acute hospital admission. Around 30 million people in Europe have heart failure and its incidence is still increasing: more cases are being identified, more people are living to an old age, and more are surviving a heart attack but with damage to the heart muscle. Yet traditional risk-factor prediction models have only limited accuracy in this population to identify those at highest risk for worsening outcomes.

So far, those risk prediction models have relied on measurements of a biomarker known as pro-B-type natriuretic peptide (BNP) for prognostic information, but studies have provided inconsistent and often inaccurate results. Measurements of troponin have been previously used in some types of cardiovascular disease, but the standard assays were not sufficiently sensitive to detect relevant changes in most heart failure patients. Now, the introduction of highly sensitive troponin assays has improved accuracy and allowed the detection of even small concentration changes.

This latest study assessed the prognostic value of the new high-sensitive assay with nanotechnology (ie, within the nanogram per litre range) in patients admitted to hospital with heart failure. The investigation, part of the Veteran Affairs Effects of Therapy study, was performed at the San Diego Veteran Affairs Medical Center in California, USA, in which 144 patients with acute heart failure were followed from admission to 90 days post-discharge.

Troponin I and BNP levels were checked on admission, discharge, and up to four consecutive days during hospitalisation. Thirty-eight of the 144 patients reached the study's primary endpoint of mortality or heart failure-related readmission and 22 patients had died by 90 days.

Using the new high sensitive assay, troponin measurements could be quantified in more than 99% of serum samples taken from all patients in the study. Analysis showed that levels in the higher quartile ranges (even at these small nanogram levels) were significantly associated with increased risk of mortality and readmission; patients with increasing levels during treatment also had higher mortality rates than those with stable or decreasing levels. The associations with troponin were statistically significant, while those with BNP were not.

The investigators drew three conclusions from the study:

Troponin levels are measurable in virtually all heart failure patients with the use of a high sensitive assay Even small elevations in troponin during hospitalisation for heart failure are associated with increased 90-day mortality and readmission Serial increases in troponin concentrations during hospitalisation are associated with higher mortality than stable or decreasing levels.

Commenting on the study, co-investigator Dr Yang Xue from the Division of Cardiology, University of California at San Diego, acknowledged that heart failure is a complex disease and that no single biomarker is likely to be fully predictive. However, because troponin is a marker for myocardial damage (a significant cause of heart failure), its accurate measurement in combination with other biomarkers will help provide a more comprehensive evaluation - and certainly more accurate than BNP alone.

Said Dr Xue: "The fact that 99% of our samples had measurable levels highlights the feasibility of measuring troponin in virtually all heart failure patients. This was simply not possible with earlier assays. But it did allow us to detect a trend of increasing troponin levels during the 90-day study period which was significantly associated with an increased risk of mortality which was not evident in patients with stable or decreasing levels. These findings may help identify a previously unidentified subgroup of high-risk patients who need closer monitoring in hospital and post-discharge."

###

Contact:

Celine Colas
ESC Press Office
European Society of Cardiology
Tel: +33(0) 492 94 86 27
Fax: +33(0)4 92 94 86 69
Email: press@escardio.org

The European Journal of Heart Failure http://www.escardio.org/journals/european-journal-heart-failure/Pages/about.aspx is a journal of the European Society of Cardiology.

Heart failure http://www.escardio.org/hfa is characterised by a cluster of symptoms resulting from the heart's inability to pump blood as required by the body. This is usually because of previous damage to the heart muscle, following a heart attack, coronary disease or hypertension. The resulting symptoms of heart failure are breathlessness, exercise intolerance, and a build-up of fluid in the lungs and abdomen.

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure simplify the definitions of new, transient and chronic disease. The 2008 ESC Guidelines can be seen in various formats here. http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/acute-chronic-heart-failure.aspx

More information on this press release and a PDF of the paper is available from the ESC's press office press@escardio.org

END



ELSE PRESS RELEASES FROM THIS DATE:

UC Davis study: Wild salmon decline was not caused by sea lice from farm salmon

2010-12-14
A new UC Davis study contradicts earlier reports that salmon farms were responsible for the 2002 population crash of wild pink salmon in the Broughton Archipelago of western Canada. The Broughton crash has become a rallying event for people concerned about the potential environmental effects of open-net salmon farming, which has become a $10 billion industry worldwide, producing nearly 1.5 million tons of fish annually. The new study, to be published online this week in Proceedings of the National Academy of Sciences, does not determine what caused the crash, but it ...

Researchers make critical leukemia stem cell discovery

2010-12-14
Researchers at King's College London have discovered that leukaemic stem cells can be reversed to a pre-leukaemic stage by suppressing a protein called beta-catenin found in the blood. They also found that advanced leukaemic stem cells that had become resistant to treatment could be 're-sensitised' to treatment by suppressing the same protein. Professor Eric So, who led the study at the Department of Haematology at King's College London, says the findings, published today in the journal Cancer Cell, represent a 'critical step forward' in the search for more effective ...

Bering Sea was ice-free and full of life during last warm period, study finds

2010-12-14
Deep sediment cores retrieved from the Bering Sea floor indicate that the region was ice-free all year and biological productivity was high during the last major warm period in Earth's climate history. Christina Ravelo, professor of ocean sciences at the University of California, Santa Cruz, will present the new findings in a talk on December 13 at the fall meeting of the American Geophysical Union (AGU) in San Francisco. Ravelo and co-chief scientist Kozo Takahashi of Kyushu University, Japan, led a nine-week expedition of the Integrated Ocean Drilling Program (IODP) ...

Ovarian cancer advances when genes are silenced

2010-12-14
DURHAM, N.C. – There are many mechanisms that alter the activity of genes – direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells. Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced ...

Parkinson's disparities

2010-12-14
Baltimore, MD – Dec. 13, 2010. African American patients and those with lower socioeconomic status have more advanced disease and greater disability when they seek treatment from Parkinson's disease specialists, according to a study from the University of Maryland School of Medicine. The researchers found that race, education and income were each significant and independent factors in determining a patient's level of disability. The disparities in health care are associated with greater disease severity and earlier loss of independence. The study is published in the December ...

Freshwater sustainability challenges shared by Southwest and Southeast, researchers find

2010-12-14
Athens, Ga. – Water scarcity in the western U.S. has long been an issue of concern. Now, a team of researchers studying freshwater sustainability in the U.S. have found that the Southeast, with the exception of Florida, does not have enough water capacity to meet its own needs. Twenty-five years ago, environmentalist Marc Reisner published Cadillac Desert: The American West and Its Disappearing Water, which predicted that water resources in the West would be unable to support the growing demand of cities, agriculture and industry. A paper co-authored by a University ...

Assessing the environmental effects of tidal turbines

Assessing the environmental effects of tidal turbines
2010-12-14
Harnessing the power of ocean tides has long been imagined, but countries are only now putting it into practice. A demonstration project planned for Puget Sound will be the first tidal energy project on the west coast of the United States, and the first array of large-scale turbines to feed power from ocean tides into an electrical grid. University of Washington researchers are devising ways to site the tidal turbines and measure their environmental effects. Brian Polagye, UW research assistant professor of mechanical engineering, will present recent findings this week ...

Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers

Capasso lab demonstrates highly unidirectional whispering gallery microlasers
2010-12-14
Cambridge, Mass., December 6, 2010 – Utilizing a century-old phenomenon discovered in St. Paul's Cathedral, London, applied scientists at Harvard University have demonstrated, for the first time, highly collimated unidirectional microlasers. The result of a collaboration with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, and the Institute of Theoretical Physics of the University of Magdeburg, Germany, the advance has a wide range of new applications in photonics such as sensing and communications. Published online this week in the Proceedings of the ...

Calculating tidal energy turbines' effects on sediments and fish

Calculating tidal energy turbines effects on sediments and fish
2010-12-14
VIDEO: This is a computer simulation of how sediment particles suspended in the water would change as they pass through a tidal turbine. Some particles speed up (turn red) as they... Click here for more information. The emerging tidal-energy industry is spawning another in its shadow: tidal-energy monitoring. Little is known about tidal turbines' environmental effects and environmentalists, regulators and turbine manufacturers all need more data to allow the industry ...

Indian study reveals that three-quarters of hip fracture patients are vitamin D deficient

2010-12-14
A study from New Delhi India has revealed high rates of vitamin D deficiency among hip fracture patients, confirming the conclusions of similar international studies which point to vitamin D deficiency as a risk factor for hip fracture. A group of 90 hip fracture patients was compared to a matched control group of similar age, sex and co-morbidity. Of the patients who had suffered hip fractures, 76.7% were shown to be vitamin D deficient as measured by serum 25(OH)D levels of less than 20 ng/ml. In addition, 68.9% had elevated PTH levels. In comparison, only 32.3% of ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Nano-measurement of troponin levels proves an accurate predictor of deterioration in heart failure
Simple blood tests with new high sensitive assay show that even small changes accurately forecast 90-day prognosis